Can surveillance systems identify and avert adverse drug events? A prospective evaluation of a commercial application.
about
Criteria for assessing high-priority drug-drug interactions for clinical decision support in electronic health recordsClinical decision support for drug related events: Moving towards better preventionCompliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin.Adverse drug events with hyperkalaemia during inpatient stays: evaluation of an automated method for retrospective detection in hospital databasesA survey of nursing home physicians to determine laboratory monitoring adverse drug event alert preferencesComputerized detection of adverse drug reactions in the medical intensive care unitA systematic review to evaluate the accuracy of electronic adverse drug event detectionReal-time pharmacy surveillance and clinical decision support to reduce adverse drug events in acute kidney injury: a randomized, controlled trialDrug-drug interactions that should be non-interruptive in order to reduce alert fatigue in electronic health records.Detection of pharmacovigilance-related adverse events using electronic health records and automated methods.Text mining for the Vaccine Adverse Event Reporting System: medical text classification using informative feature selection.Methods for assessing the preventability of adverse drug events: a systematic review.A computerized adverse drug event alerting system using clinical rules: a retrospective and prospective comparison with conventional medication surveillance in the Netherlands.
P2860
Q26999857-BC2E468F-FCFA-4A4F-90DA-F1C9A3F5F035Q28067548-136F5403-7BB4-4350-B723-A0C221DB5AE1Q33385883-5E12000D-E9E6-4BCF-B6A1-B1C829EE5833Q34184832-D474B990-24DC-47CB-873D-9E2586BD68ADQ34877194-A588C48E-8A56-4BD4-8B75-E11C0FE9F7E9Q35114077-9CCAE5BC-7761-43C5-9853-B388AFF3F118Q35619108-37B65956-ED67-4BDF-93F0-A264A5AA80A0Q36039089-2E591514-F59F-429A-BDBC-BC18316A9DA8Q36771140-292518F9-885F-43B7-8A8F-2532C419722BQ36936563-888B58F7-784A-40B9-9C02-260C43E5E64EQ37895032-7E9E006A-8635-40B9-B4B5-A73E51FF2834Q37971470-42974532-B2C1-4EF2-8F76-BD57663B9365Q51055688-5213836A-8A1A-481E-B268-71A923C4BC8D
P2860
Can surveillance systems identify and avert adverse drug events? A prospective evaluation of a commercial application.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Can surveillance systems ident ...... n of a commercial application.
@en
type
label
Can surveillance systems ident ...... n of a commercial application.
@en
prefLabel
Can surveillance systems ident ...... n of a commercial application.
@en
P2093
P2860
P356
P1476
Can surveillance systems ident ...... n of a commercial application.
@en
P2093
Andrew Seger
Ashish K Jha
David W Bates
Julia Laguette
P2860
P304
P356
10.1197/JAMIA.M2634
P577
2008-06-25T00:00:00Z